HOMELAND DEFENSE

& Security Digest

6 SEPTEMBER 2022

HDIAC collects and publishes articles related to our technical focus areas on the web to share with the DoD community.

FEATURED ARTICLE

FDA Approves New Drug Application for the DoD’s Advanced Anticonvulsant System Program

FORT DETRICK, Md. – August 23, 2022 – The Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense’s (JPEO-CBRND’s) Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical (JPM CBRN Medical) received notice of U.S. Food and Drug Administration (FDA) approval of Rafa Laboratories, Ltd.’s (Rafa) midazolam injection autoinjector New Drug Application…

Read More...

Featured Notable Technical Inquiry

Wearable Sensors for Human Emotion and Sentiments

As there are few U.S.-based biometric sensor platforms capable of real-time emotion detection, HDIAC expanded this inquiry to include a limited number of systems developed internationally. Relevant information, including primary point of contact, email, phone number, and a brief description of the solution, is provided.

Learn More

FUTURE WEBINARS

HDIAC hosts live online technical presentations featuring a DoD research and engineering topic within our technical focus areas.

Microgrid Solutions for DoD Mission Energy Assurance

Hosted by: Joel Hewett

December 8, 2022 12:00 pm

Nuclear Deterrence

Hosted by: Robert J. Hill

September 28, 2022 12:00 pm
DID YOU MISS OUR LAST WEBINAR?

UPCOMING WEBINAR

Nuclear Deterrence

Nuclear deterrence is the ability to deter nuclear weapons use by adversaries and dissuade nonnuclear great power conflict by credibly threatening catastrophic retaliation. This webinar will discuss U.S. nuclear deterrence theory, the role of our nuclear deterrent capabilities, foundations of nuclear command and control, organizations of the U.S. nuclear enterprise, and our global nuclear adversaries….

Read More...

UPCOMING EVENTS

Joint Air Survivability Summit 2024

The 2024 Joint Air Survivability Summit will highlight key threats posed to aerial platforms from adversaries and the innovative technologies or strategies, which may be used to counter them. At this forum, senior-level speakers will…

The 2024 FAA Drone and Advanced Air Mobility Symposium

Previously two separate events, the 2024 Federal Aviation Administration’s (FAA’s) Drone and Advanced Air Mobility (AAM) Symposium is the first time both communities are connected to discuss safety and emerging technologies for our shared skies….

Public Health in a Migrant Crisis Tabletop Exercise

THIS IS AN IN-PERSON, COLLABORATIVE EVENT.   In 2022, there were over 100 million displaced persons globally, a number that only continues to grow. Because one region’s instability bleeds into its surrounding areas, it is all…

National Homeland Security Conference 2024

The National Homeland Security Conference brings together professionals in homeland security, law enforcement, fire, and emergency management. They include officials in federal agencies, nonprofit agencies, business owners, universities, and decision-makers to contribute or learn about…

17th International Detonation Symposium

The International Detonation Symposium started in 1951 and was originally a Navy-sponsored discussion of about 17 papers. In subsequent years, it has been sponsored by U.S. Department of Defense and Energy labs and has grown…

Voice From the Community

Winegar Richard Headshot1
Richard Winegar, Ph.D

Chief Scientist, MRIGlobal

Richard Winegar’s work has contributed to national security and areas in genomics, such as whole genome sequencing and reference capability, and diagnostic assays for biothreat agents and radiation exposure. Previously, he helped develop and validate methods to analyze evidence related to the 2001 anthrax letters investigation for the U.S. Department of Justice. He has served as principal investigator for many U.S. government and commercial clients. He characterized genetic damage induced by heavy-ion particle radiation for NASA and used PCR to determine tissue distribution in mice of an adenovirusbased, antimelanoma vaccine for NCI. More recently, he played a role in developing rapid diagnostics, testing therapeutics, and performing genomic analysis to better understand the emergence and significance of COVID-19 variant strains.

Want to be featured in our Digest?

Submit your "Voice From the Community"